Literature DB >> 25559976

The influence of bromocryptine treatment on activity of the adenylyl cyclase system in the brain of rats with type 2 diabetes mellitus induced by high-fat diet.

A O Shpakov1, K V Derkach, O V Chistyakova, V M Bondareva.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25559976     DOI： 10.1134/S1607672914060027

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN： 1607-6729            Impact factor:   0.788


× No keyword cloud information.
  11 in total

Review 1.  Relaxin in vascular physiology and pathophysiology: possible implications in ischemic brain disease.

Authors:  Silvia Nistri; Daniele Bani
Journal:  Curr Neurovasc Res       Date:  2005-07       Impact factor: 1.990

Review 2.  [The brain peptidergic signaling systems in diabetes mellitus].

Authors:  A O Shpakov; K V Derkach
Journal:  Tsitologiia       Date:  2012

Review 3.  The role of bromocriptine-QR in the management of type 2 diabetes expert panel recommendations.

Authors:  Alan J Garber; Lawrence Blonde; Zachary T Bloomgarden; Yehuda Handelsman; Samuel Dagogo-Jack
Journal:  Endocr Pract       Date:  2013 Jan-Feb       Impact factor: 3.443

4.  Activation of D1 and D2 dopamine receptors increases the activity of the somatostatin receptor-effector system in the rat frontoparietal cortex.

Authors:  R M Izquierdo-Claros; M del Boyano-Adánez; E Arilla-Ferreiro
Journal:  J Neurosci Res       Date:  2000-10-01       Impact factor: 4.164

5.  Long-term administration of the dopamine D3/2 receptor agonist pramipexole increases dopamine and serotonin neurotransmission in the male rat forebrain.

Authors:  Olga Chernoloz; Mostafa El Mansari; Pierre Blier
Journal:  J Psychiatry Neurosci       Date:  2012-02       Impact factor: 6.186

Review 6.  Depression in diabetic patients: the relationship between mood and glycemic control.

Authors:  Patrick J Lustman; Ray E Clouse
Journal:  J Diabetes Complications       Date:  2005 Mar-Apr       Impact factor: 2.852

7.  Antibodies as pharmacologic tools for studies on the regulation of energy balance.

Authors:  Karl G Hofbauer; Anne-Catherine Lecourt; Jean-Christophe Peter
Journal:  Nutrition       Date:  2008-07-26       Impact factor: 4.008

8.  Beta-adrenergic receptor activity of cerebral microvessels in experimental diabetes mellitus.

Authors:  A D Mooradian; P J Scarpace
Journal:  Brain Res       Date:  1992-06-26       Impact factor: 3.252

9.  Effect of bromocriptine-QR (a quick-release formulation of bromocriptine mesylate) on major adverse cardiovascular events in type 2 diabetes subjects.

Authors:  J Michael Gaziano; Anthony H Cincotta; Aaron Vinik; Lawrence Blonde; Nancy Bohannon; Richard Scranton
Journal:  J Am Heart Assoc       Date:  2012-10-25       Impact factor: 5.501

Review 10.  The functional state of hormone-sensitive adenylyl cyclase signaling system in diabetes mellitus.

Authors:  Alexander O Shpakov; Kira V Derkach
Journal:  J Signal Transduct       Date:  2013-09-28
View more
  1 in total

Review 1.  Brain signaling systems in the Type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases.

Authors:  Alexander O Shpakov; Kira V Derkach; Lev M Berstein
Journal:  Future Sci OA       Date:  2015-11-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.